Effects of low dose OKT3 induction on the antitumor immune response in cancer patients receiving interleukin-2 (IL-2) and tumor necrosis factor-alpha (TNF)

S. C. Yang, E. A. Grimm, J. A. Roth

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)434-436
Number of pages3
JournalSurgical forum
StatePublished - Dec 1 1990
Externally publishedYes

ASJC Scopus subject areas

  • Surgery

Cite this